Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRospective Prostate biOmarker Study (PROPOSe)

NCT03565289 is registered in ClinicalTrials.gov with ProteoMediX AG as lead sponsor.

NCT NCT03565289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03565289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRospective Prostate biOmarker Study (PROPOSe)
Lead sponsor
ProteoMediX AG
Phase
Observational
Overall status
Completed
Start date
August 14, 2018
Completion date
January 31, 2020
Enrollment
455 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

indication for prostate biopsy due to suspected prostate cancer